SCHEMBL25577418

SCHEMBL25577418

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2N(c2ccc(-c3ccc4c(c3)oc3ccccc34)cc2)c2cccc3c2oc2ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.39
▸ PRKDC P78527 1/20 0.36
▸ MMP12 P39900 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ GGPS1 O95749 1/20 0.32
▸ PLA2G2A P14555 3/20 0.32
▸ PLA2G4A P47712 3/20 0.32
▸ AHR P35869 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HCRTR1 O43613 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ PLA2G10 O15496 1/20 0.31
▸ PTGES2 Q9H7Z7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25578783 0.95 ALOX5 (0.41) ALOX5PRKDCGGPS1PLA2G2APLA2G4A
SCHEMBL25577615 0.94 ALOX5 (0.40) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL25577643 0.94 ALOX5 (0.44) ALOX5PRKDCMMP12MMP13GGPS1
SCHEMBL25577430 0.94 ALOX5 (0.39) ALOX5PRKDCGGPS1PLA2G2APLA2G4A
SCHEMBL25578841 0.93 ALOX5 (0.40) ALOX5PRKDCGGPS1PLA2G2APLA2G4A
SCHEMBL25578851 0.93 ALOX5 (0.40) ALOX5PRKDCGGPS1PLA2G2APLA2G4A
SCHEMBL25579352 0.92 MMP12 (0.36) ALOX5PRKDCMMP12MMP13PLA2G2A
SCHEMBL25579258 0.92 MMP12 (0.36) ALOX5PRKDCMMP12MMP13PLA2G2A
SCHEMBL25579380 0.92 MMP12 (0.38) ALOX5PRKDCMMP12MMP13PLA2G2A
SCHEMBL25579364 0.92 MMP12 (0.38) ALOX5PRKDCMMP12MMP13PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 ALOX5 1615/4885PRKDC 4878/4885MMP12 3690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback